Atlas Trials

A Phase 1 Study of AV-380 in Healthy Subjects

Clinical trial NCT04815551 · COMPLETED

Trial details

NCT number
NCT04815551
Sponsor
AVEO Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cachexia
Start date
2021-02-22
Primary completion
2022-01-14
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.